Additional Early Option Exercise Payment Clause Samples

Additional Early Option Exercise Payment. If Licensee elects to exercise the Lead Option pursuant to Section 4.3.2(a)(i), Kineta will be eligible for a one-time payment in the amount of [***] following the first dosing of a patient in a Phase I Clinical Trial for the Licensed Product. Licensee will make such payments in accordance with Section 6.3.5. Each such payment shall be non-creditable and non-refundable. Kineta-Genentech Exclusive Option and License Agreement